TickerFacts.

Translational Development Acquisition Corp. (TDAC): Operating Cash Flow

Annual figures by period end, from SEC filings.

-$608.4K
Year ended 2025-12-31
-$849.4K
Trailing 12 months to 2026-06-30
2023-12-31: -$2042024-12-31: -$851.4K2025-12-31: -$608.4K-$608.4K
2023-12-31 Operating Cash Flow (USD) 2025-12-31
Period endedOperating Cash FlowChange YoYSource filing
2025-12-31-$608.4Kn/m2026-03-30, From 2025-01-01
2024-12-31-$851.4Kn/m2026-03-30, From 2024-01-01
2023-12-31-$204n/a2025-03-31, From 2023-01-01

Operating Cash Flow at similar companies

Companies with the same SEC industry code (Blank Checks), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedOperating Cash FlowChange YoY
Translational Development Acquisition Corp. (TDAC)2025-12-31-$608.4Kn/m
Newbury Street II Acquisition Corp (NTWO)2025-12-31-$464.7Kn/a
Globa Terra Acquisition Corp (GTERA)2025-12-31-$437.1Kn/a
Copley Acquisition Corp (COPL)2025-12-31-$469.0Kn/a
1RT Acquisition Corp. (ONCH)2025-12-31-$497.4Kn/a
Dynamix Corp (DYNC)2025-12-31-$2.03Mn/a
Twelve Seas Investment Co III/Cayman (TWLV)2025-12-31-$252.2Kn/a
Oaktree Acquisition Corp. III Life Sciences (OACC)2025-12-31-$422.1Kn/a
Thayer Ventures Acquisition Corp II (TVAI)2025-12-31$617.1Kn/a

Compare TDAC, NTWO, GTERA, COPL side by side · Screen every company in Blank Checks ↗